1、1Greater Phoenix:An Emerging Bioscience HubThis report focuses on a cluster of industries including medical device and medical technology manufacturing,clinical and translational research,biotechnology,genomics,and pharmaceutical manufacturing,among others.The Greater Phoenix region has adopted the

2、term“bioscience”to refer to this cluster.CBRE uses the term“life science.”They are used interchangeably in this report.Copyright 2024 All rights reserved.Information contained herein,including projections,has been obtained from sources believed to be reliable,but has not been verified for accuracy o

3、r completeness.CBRE,Inc.makes no guarantee,warranty or representation about it.Any reliance on such information is solely at your own risk.This information is exclusively for use by CBRE clients and professionals and may not be reproduced without the prior written permission of CBREs Global Chief Ec

4、onomist.Executive SummaryGreater Phoenix Bioscience RootsLocal Innovation Regional DemographicsIndustries,Employment,&Specialized WorkforceEducation&Talent PipelineEmerging Bioscience CorridorsPhoenix Bioscience CoreOperating CostsInnovation Funding&Capital TrendsRegional Healthcare Assets&Clinical

5、TrialsT able of Contents011505212725031711233921Greater Phoenix:An Emerging Bioscience HubGreater Phoenixs dedication to fostering innovation,research and development(R&D),collaboration,and expansion in the bioscience sector continues to draw companies in the industry to the metro.The markets succes

6、s in this field is largely due to low barriers of entry,a growing population and an entrepreneurial ethos.By continuing to utilize its distinct advantages,Greater Phoenix aims to realize a grand vision of becoming a global front-runner in the bioscience industry.NATION-LEADING GROWTH By almost any r